Christine Charon is a pharmaceutical scientist with over ten years experience in the research and development, of pharmaceutical product therapeutics for insulin resistance, types 2 diabetes, and obesity. Christine has extensive expertise in Medium Throughput Screening, functional and characterization assays and in the follow up of pre clinical research projects as Leader Project Manager. Christine’s previous corporate experiences includes positions in drug discovery at Merck KgAa in Biochemistry. She received her Ph.D. in Pathophysiology, Molecular & Cellular Biology of nutritional & inflammatory diseases from Paris VI University and received post-doctoral training in molecular biology, cell biology and physiology in Germany (Max-Planck Institute, Bad Nauheim) and in US (NIH, Bethesda, MA).
Molecular Biology.